NEW YORK - An assistant principal died yesterday, the city's first fatality linked to the swine flu virus. Mitchell Wiener, 55, who worked at Susan B. Anthony middle school in Queens, had been sick for nearly a week before his school ...Read More
* WHO confirms first shipment of 1.1 mln doses to Cuba * Nigeria, Kenya and S. Africa among dozen to get doses * Virus continues to spread in West Africa * Experts to examine WHO handling of pandemic April 12-14 GENEVA, March 19 (Reuters) ...Read More
* FDA expresses concern about drugs administration system Stocks | Regulatory News | Healthcare * FDA found deficiencies in co's manufacturing facilities * FDA asks for more trials * Shares sink 64 pct in premarket trade March 19 (Reuters) - A.P. Pharma Inc (APPA.O) said ...Read More
CHARLOTTE, N.C. - Chelsea Therapeutics International Ltd. said Wednesday its potential blood pressure drug Northera boosted blood pressure levels in patients over a 24-hour period. The company said the study focused on 18 patients who are enrolled in an ongoing late-stage ...Read More
March 16, 2010 -- It's no wildfire, but H1N1 swine flu continues to smolder in the U.S. From mid-January to mid-February, the CDC estimates there were 2 million new cases of H1N1 swine flu, causing 18,000 hospitalizations, and about 310 deaths. From ...Read More
ZURICH-Roche Holding AG's recent drug-trial failures have increased pressure on the Swiss pharmaceutical company as it seeks to become a powerhouse after the takeover of U.S. biotechnology firm Genentech. During the past two weeks, Roche has suffered several drug-development setbacks. The ...Read More
Swine flu came in like a lion but seems to be going out like a lamb. And the regular flu season never even got started. After scaring the bejeebers out of us last spring and fall, the H1N1 virus seems to ...Read More
About 12,000 Americans died from swine flu between its emergence last April until mid-February, the Centers for Disease Control and Prevention estimated on Friday. While swine flu is still being transmitted at low levels and some people still die of ...Read More
ZURICH (Dow Jones)--Roche Holding AG's (RHHBY) recent drug trial failures involving some of its most potent products have increased pressure on the Swiss firm ahead of its investor day on whether it can meet market hopes to turn into the ...Read More
For much of 2009, the swine flu was the biotech industry's cash cow. The virus's sudden contagion last spring spread rapidly and lucratively to the local life sciences community, where a handful of companies scrambled to assemble enough money and ...Read More
* 2 Sutent breast cancer trials fail to meet goals * Figitumumab lung cancer trial stopped (Adds background, share price) LOS ANGELES, March 11 (Reuters) - Pfizer Inc (PFE.N) said on Thursday that two late-stage breast cancer trials involving its cancer drug ...Read More
The H1N1 swine flu outbreak appears to have ended less like the rogue wild boar that United Nations bureaucrats predicted and more like roasted pork tenderloin with apples and sage. From the beginning the World Health Organization's actions have ranged ...Read More
WEDNESDAY, March 10 (HealthDay News) -- The H1N1 swine flu appears to spread more slowly than "regular" seasonal flu in a household setting, but when it does spread it's more likely to affect children, a new study suggests. "We found that ...Read More
WASHINGTON -- Federal health advisers on Tuesday voted in favor of an experimental drug from InterMune Inc., despite mixed evidence of whether it provides significant benefits for patients with a rare lung disease. The Food and Drug Administration's panel of lung ...Read More
* FDA advisers vote 9-3 to back drug Stocks | Regulatory News | Healthcare SILVER SPRING, Md., March 9 (Reuters) - U.S. medical advisers backed InterMune Inc's (ITMN.O) experimental drug to treat lung scarring on Tuesday, saying it should be approved for ...Read More
LONDON (Reuters) - Europe is unlikely to see another wave of pandemic H1N1 flu soon but local epidemics are likely as winter returns to the Northern hemisphere, health officials said on Monday. The European Center for Disease Prevention and Control (ECDC) ...Read More
ZURICH (Reuters) – Swiss drugmaker Roche Holding AG and U.S. biotechnology company Biogen Idec are suspending experimental rheumatoid arthritis and lupus treatment ocrelizumab after deaths following its use, casting doubt over its future. Roche and Biogen stopped using the experimental drug ...Read More
ZURICH--Roche Holding AG and Biogen Idec Inc. said Monday they suspended a rheumatoid arthritis program using drug candidate ocrelizumab because of safety concerns, further cutting the experimental drug's market potential. The suspension was recommended by the independent Data and Safety Monitoring ...Read More
* Recentin fails vs Roche's Avastin in late stage study * Analysts say data as expected, Crestor verdict next hurdle * More late stage Recentin trial data due in coming months * AstraZeneca's shares fall more than 1.7 percent LONDON, March 8 (Reuters) - ...Read More
Intermune shares surge as FDA reviews lung drug WASHINGTON — Shares of drug developer InterMune Inc. surged Friday after federal health officials posted their review of the experimental drug pirfenidone, which is designed to treat a rare lung disease. The stock advanced ...Read More
